450 A Belgian multicenter phase II randomized trial in HER2-negative metastatic breast cancer evaluating consolidation antiangiogenic therapy with sunitinib after objective response to taxane-based chemotherapy
H. Wildiers, C. Fontaine, P. Vuylsteke, M. Martens, J.L. Canon, W. Wynendaele, C. Focan, J. DeGreve, P. Squifflet, R. ParidaensVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70471-7
File:
PDF, 47 KB
english, 2010